126 related articles for article (PubMed ID: 37329524)
1. Insights into the Role of Erythrina corallodendron L. in Alzheimer's Disease: in Vitro and in Silico Approach.
Salem AM; Mostafa NM; Al-Sayed E; Fawzy IM; Singab ANB
Chem Biodivers; 2023 Jul; 20(7):e202300200. PubMed ID: 37329524
[TBL] [Abstract][Full Text] [Related]
2. Lepidine B from Lepidium sativum Seeds as Multi-Functional Anti- Alzheimer's Disease Agent: In Vitro and In Silico Studies.
Talia S; Benarous K; Lamrani M; Yousfi M
Curr Comput Aided Drug Des; 2021; 17(3):360-377. PubMed ID: 32116197
[TBL] [Abstract][Full Text] [Related]
3. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean
Tallini LR; Bastida J; Cortes N; Osorio EH; Theoduloz C; Schmeda-Hirschmann G
Molecules; 2018 Jun; 23(7):. PubMed ID: 29949847
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease.
Conceição RAD; von Ranke N; Azevedo L; Franco D; Nadur NF; Kummerle AE; Barbosa MLC; Souza AMT
J Cell Biochem; 2023 Nov; 124(11):1734-1748. PubMed ID: 37796142
[TBL] [Abstract][Full Text] [Related]
6. Alkaloids of Zephyranthes citrina (Amaryllidaceae) and their implication to Alzheimer's disease: Isolation, structural elucidation and biological activity.
Kohelová E; Maříková J; Korábečný J; Hulcová D; Kučera T; Jun D; Chlebek J; Jenčo J; Šafratová M; Hrabinová M; Ritomská A; Malaník M; Peřinová R; Breiterová K; Kuneš J; Nováková L; Opletal L; Cahlíková L
Bioorg Chem; 2021 Feb; 107():104567. PubMed ID: 33387730
[TBL] [Abstract][Full Text] [Related]
7. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
Kumar V; Saha A; Roy K
Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease.
Adeowo FY; Elrashedy AA; Ejalonibu MA; Lawal IA; Lawal MM; Kumalo HM
Mol Divers; 2022 Oct; 26(5):2761-2774. PubMed ID: 35067751
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
10. Alkaloids from flowers of Erythrina corallodendron.
Zhao HE; Wu J; Xu FQ; Bao MF; Jin CS; Cai XH
Nat Prod Res; 2019 May; 33(9):1298-1303. PubMed ID: 29873265
[TBL] [Abstract][Full Text] [Related]
11. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
Daoud I; Melkemi N; Salah T; Ghalem S
Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase Inhibitory and
Senol Deniz FS; Ekhteiari Salmas R; Emerce E; Sener B; Orhan IE
CNS Neurol Disord Drug Targets; 2024; 23(6):773-783. PubMed ID: 37073143
[TBL] [Abstract][Full Text] [Related]
13. In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.
Innok W; Hiranrat A; Chana N; Rungrotmongkol T; Kongsune P
J Comput Aided Mol Des; 2021 Mar; 35(3):325-336. PubMed ID: 33439402
[TBL] [Abstract][Full Text] [Related]
14. Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
Bowroju SK; Penthala NR; Lakkaniga NR; Balasubramaniam M; Ayyadevara S; Shmookler Reis RJ; Crooks PA
Bioorg Med Chem; 2021 Sep; 45():116311. PubMed ID: 34304133
[TBL] [Abstract][Full Text] [Related]
15. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
[TBL] [Abstract][Full Text] [Related]
16. Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent.
Miao S; He Q; Li C; Wu Y; Liu M; Chen Y; Qi S; Gong K
Pharm Biol; 2022 Dec; 60(1):1502-1510. PubMed ID: 35968601
[TBL] [Abstract][Full Text] [Related]
17. Amaryllidaceae Alkaloids of Belladine-Type from
Al Mamun A; Maříková J; Hulcová D; Janoušek J; Šafratová M; Nováková L; Kučera T; Hrabinová M; Kuneš J; Korábečný J; Cahlíková L
Biomolecules; 2020 May; 10(5):. PubMed ID: 32455879
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
19. Geissoschizoline, a promising alkaloid for Alzheimer's disease: Inhibition of human cholinesterases, anti-inflammatory effects and molecular docking.
Lima JA; R Costa TW; da Fonseca ACC; do Amaral RF; Nascimento MDDSB; Santos-Filho OA; de Miranda ALP; Ferreira Neto DC; Lima FRS; Hamerski L; Tinoco LW
Bioorg Chem; 2020 Nov; 104():104215. PubMed ID: 32920358
[TBL] [Abstract][Full Text] [Related]
20. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
